Stay updated with breaking news from Block Purchase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novo Nordisk A/S and BIOCORP Production SA announced on June 5 that Novo Nordisk has entered into exclusive negotiations for a controlling stake in BIOCORP, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in BIOCORP1 at a price of 35.00 Euros per share in cash, representing a total equity value of approximately 154 million Euros.
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP's main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.19%
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP’s main shareholder, for the purchase of its entire stake in BIOCORP,...
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP’s main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.19% of its theoretical voting rights, at a price of 35.00 Euros per share.Certain minority shareholders, representing 19,0% of...
Proposed acquisition by CGI of a stake in Umanis representing 70.6% of the share capital and 81.9% of the voting rights from Mura and M. Olivier Pouligny, followed by the filing of a simplified